Percutaneous transhepatic cholangiography PTC - Biotech, Pharma and Life Science Channel

07:40 EDT 2nd September 2014 | BioPortfolio

PubMed Articles [1084 Associated PubMed Articles listed on BioPortfolio]

Spironolactone lowers the rate of repeat revascularization in acute myocardial infarction patients treated with percutaneous coronary intervention.

We sought to assess the effect of the aldosterone receptor blocker, spironolactone, on 1-year clinical outcomes in all-comers with acute myocardial infarction (AMI) undergoing percutaneous coronary in...

Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: Insights from the Veterans Affairs CART Program.

Delays in filling clopidogrel prescriptions after percutaneous coronary intervention (PCI) have been demonstrated previously and associated with adverse outcomes.

Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008.

With conflicting evidence regarding the usefulness of intraaortic balloon pump (IABP), reports of IABP use in the United States have been inconsistent. Our objective was to examine trends in IABP usag...

Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: A meta-analysis of individual patient data.

Erythropoiesis-stimulating agents (ESAs) have been investigated in small studies in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI)...

Assessment of side branch predilation before a provisional T-stent strategy for bifurcation lesions. A randomized trial.

A simple approach is the predominant strategy for the percutaneous coronary intervention of bifurcation lesions. Performing side branch (SB) predilation in this context is currently a matter of contro...

Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention.

The American Heart Association recommends targeting 7 cardiovascular (CV) health metrics to reduce morbidity and mortality. Control of these targets in patients undergoing CV intervention is uncertain...

Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial.

Biodegradable polymers for release of antiproliferative drugs from metallic drug-eluting stents aim to improve long-term vascular healing and efficacy. We designed a large scale clinical trial to comp...

Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations.

Bleeding after percutaneous coronary intervention (PCI) is identified as a strong predictor for adverse events, including mortality. This study aims to compare the incidence and correlates of post-PCI...

Totally Tubeless versus Standard Percutaneous Nephrolithotomy for Renal Stones: Analysis of Clinical Outcomes and Cost.

Purpose: To evaluate safety and cost-effectiveness of a totally tubeless percutaneous nephrolithotomy (PCNL) by comparing the clinical outcomes and cost analysis between standard PCNL and totally tube...

The SimPORTAL Fluoro-less C-arm Trainer (CAT): An Innovative Device for Percutaneous Kidney Access.

Abstract INTRODUCTION AND OBJECTIVES: Achieving proper renal access is arguably the most challenging component of percutaneous nephrolithotomy (PCNL). A core skill required during this procedure is th...

News Articles [202 Associated News Articles listed on BioPortfolio]

Inhaled nitric oxide to heart attack patients does not reduce damaged tissue, but may improve recovery

Inhaled nitric oxide, delivered to heart attack patients before and during treatment with percutaneous coronary intervention (PCI) did not reduce the extent of damaged tissue (infarct), but may have i...

[Articles] Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

In a patient population with minimum exclusion criteria and high adherence to dual antiplatelet therapy, biodegradable polymer sirolimus-eluting stents were non-inferior to durable polymer everolimus-...

Nitric oxide inhalation in heart attack patients sends mixed messages, but may offer benefit

Inhaled nitric oxide, delivered to heart attack patients before and during treatment with percutaneous coronary intervention (PCI) did not reduce the extent of damaged tissue (infarct), but may have i...

ESC: Ultrathin Stent Proves Mettle in Post-PCI Patients (CME/CE)

BARCELONA (MedPage Today) -- An ultrathin biodegradable sirolimus-eluting stent (Orsiro) proved noninferior to a durable polymer everolimus-eluting stent (Xience) a year after percutaneous coronary in...

ESC: No Pre-PCI Boost from Brilinta in Ambulance (CME/CE)

BARCELONA (MedPage Today) -- Giving the antiplatelet drug ticagrelor (Brilinta) in the ambulance to patients with acute ST-segment elevation myocardial infarction didn't improve coronary reperfusion b...

First multidisciplinary recommendations on management of arrhythmias in ACS patients

Barcelona, Spain Saturday 30 August 2014: The first multidisciplinary recommendations on the management of arrhythmias in patients with acute coronary syndromes (ACS) are published today in EP Europ...

CardiacAssist Receives FDA 510(k) Clearance for Its PROTEK Duo Veno-Venous Cannula

Patients gain access to a new treatment option for respiratory distress CardiacAssist, Inc. today announced that it has received 510(k) clearance from the U.S. Food and...

Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI

East Asian patients are known to have differing risks of thrombophilia and bleeding compared with white patients, but few have been included in phase III trials of P2Y12 inhibitors. Therefore, the Wor...

Regado plummets on Phase III trial halt

Regado Biosciences Inc. (NASDAQ:RGDO) fell $1.71 (60%) to $1.13 on Monday after it said an independent DSMB indicated the level of serious allergic adverse events associated with Revolixys Kit was "of...

Device implanted for tricuspid valve replacement: First in United States

America’s first transcather tricuspid heart valve replacement has been performed, providing an alternative to open heart surgery, clinical scientists report. Percutaneous interventions use hollow tu...

Events [0 Results]

None

Companies [14 Associated Companies listed on BioPortfolio]

Osprey Medical Inc.

Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute. Osprey is focused on improving p...

Mitralign, Inc.

Mitralign is a cardiac device company founded by the Accelerated Technologies (ATI) medical device incubator. The company has developed and is currently testing an innovative, cat...

BioCardia, Inc.

BioCardia, Inc., headquartered in San Carlos, CA is a privately-held commercial medical technology company that has developed percutaneous delivery systems for biologics to treat ...

InSeal Medical Ltd.

InSeal Medical Ltd. (Caesarea, Israel http://www.InSealMedical.com/) develops and manufactures percutaneous vascular closure devices for sealing of puncture site following a treat...

SpineAlign Medical, Inc.

The SpineAlign device represents the first of many new innovations in the area of minimally invasive percutaneous vertebral body reconstruction and augmentation to be developed by...

Corindus Vascular Robotics

Corindus designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s disposable medical device ...

Ischemix

Ischemix is a privately-held drug discovery company with a portfolio of small molecule therapeutic compounds. The first of these compounds is targeted to reduce cell death and org...

NeuroDigm

NeuroDigm Co. is helping companies solve the puzzle of chronic pain with the Hot Spot ModelTM of Neuropathic Pain. This is THE Alternative, Nonsurgical Model to create neuropathic pain as found in ...

Colibri Heart Valve, LLC

Colibri Heart Valve, LLC is a privately held medical device company committed to the research and development of novel heart valve technologies, including the Company’s dry, ...

ETView Medical Ltd.

ETView Medical Ltd. (TASE: ETVW) is a commercial-stage, publicly traded medical device company that has successfully combined airway management with continuous direct airway vi...

Clinical Trials [419 Associated Clinical Trials listed on BioPortfolio]

Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel Disease

This is a pilot randomized study that aim to assess the safety and feasibility of a hybrid myocardial revascularization strategy (coronary artery by-pass graft and percutaneous interventio...

DES Versus BiOSS LIM - POLBOS II Study

Coronary bifurcation lesions pose therapeutic problems during percutaneous coronary interventions (PCI) and are associated with higher rates of periprocedural complications as well as high...

XIENCE XPEDITION™ in Routine Clinical Practice

The purpose of this study is to evaluate effectiveness and safety of XIENCE XPEDITION™ in Routine Clinical Practice

Intracoronary Tirofiban on No-Reflow Phenomena

The goal of this study was to evaluate the acute effect of intracoronary administration of tirofiban on no-reflow phenomenon in patients with STEMI and occurrence of no-reflow phenomenon u...

Physical Activity Telehealth Intervention After Percutaneous Coronary Procedures

The purpose of this study is to test the feasibility of using targeted daily cell phone interaction to facilitate behavior change for physical activity in previously-sedentary individuals ...

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

NG PROMUS: A Prospective, Multicenter Trial to Assess the NG PROMUS Everolimus-Eluting Platinum Chromium Coronary Stent System (NG PROMUS Stent System) for the Treatment of Atherosclerotic...

Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions

Microembolization is commonly associated with carotid artery stenting (CAS), but our understanding of subclinical microembolization is superficial. Through collaborative effects of multidi...

Identification of Microcirculation and Inflammation After Posterior Stabilization of the Spine

In this project, with unstable vertebral fractures, the microcirculation of the skin and muscle (O2C,Laser-Doppler/White-light -Spectroscopy and contrast-enhanced sonography) will be evalu...

Stanford Coronary Risk Intervention Project (SCRIP)

To determine whether modification of risk factors altered the rate of progression of coronary artery disease in arteries with mild atherosclerosis and no mechanical intervention in patient...

Thrombolysis in Myocardial Infarction (TIMI)

In TIMI I, to assess the relative thrombolytic activity and side effects of intravenous recombinant tissue-type plasminogen activator (rt-PA) versus intravenous streptokinase in patients w...

Medical and Biotech [MESH] Definitions

Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization.

Percutaneous excision of a herniated or displaced intervertebral disk by posterolateral approach, always remaining outside the spinal canal. Percutaneous nucleotomy was first described by Hijikata in Japan in 1975. In 1985 Onik introduced automated percutaneous nucleotomy which consists in percutaneous aspiration of the nucleus pulposus. It is carried out under local anesthesia, thus reducing the surgical insult and requiring brief hospitalization, often performed on an outpatient basis. It appears to be a well-tolerated alternative to surgical diskectomy and chymopapain nucleolysis.

Excision, in part or whole, of an intervertebral disk. The most common indication is disk displacement or herniation. In addition to standard surgical removal, it can be performed by percutaneous diskectomy (DISKECTOMY, PERCUTANEOUS) or by laparoscopic diskectomy, the former being the more common.

Surgery of the smooth muscle sphincter of the hepatopancreatic ampulla to relieve blocked biliary or pancreatic ducts.

A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.

Search BioPortfolio:
Advertisement
Advertisement
review and buy Percutaneous transhepatic cholangiography PTC market research data and corporate reports here

Channels Quicklinks